ELVN

$41.70+0.47 (+1.14%)

After Hours$42.50+0.80 (+1.92%)· Last close May 1

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO